Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoembolization, Therapeutic”

231 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 231 results

Not applicableUnknownNCT00730860
What this trial is testing

Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE

Who this might be right for
Cancer of Liver
Southwest Hospital, China 140
Testing effectiveness (Phase 2)Ended earlyNCT01060423
What this trial is testing

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hans-Joachim Schmoll, MD 8
Testing effectiveness (Phase 2)UnknownNCT00960518
What this trial is testing

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatitis B VirusHepatocellular Carcinoma
Tongji University 216
Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00956930
What this trial is testing

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Who this might be right for
Liver Cancer
Northwestern University 45
Large-scale testing (Phase 3)UnknownNCT00501813
What this trial is testing

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 160
Large-scale testing (Phase 3)Study completedNCT01259414
What this trial is testing

Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 812
Testing effectiveness (Phase 2)UnknownNCT04652492
What this trial is testing

Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633
What this trial is testing

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Thomas Jefferson University 28
Not applicableLooking for participantsNCT04996914
What this trial is testing

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University 30
Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Not applicableWithdrawnNCT03172559
What this trial is testing

Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto
Testing effectiveness (Phase 2)Active Not RecruitingNCT07380633
What this trial is testing

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 90
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561983
What this trial is testing

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

Who this might be right for
Unresectable Stage III Non-small Cell Lung CancerTislelizumabChemotherapy+2 more
Sichuan Cancer Hospital and Research Institute 39
Testing effectiveness (Phase 2)UnknownNCT05361161
What this trial is testing

Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)

Who this might be right for
Gastric CancerEmbolization
Gang Wu 60
Early research (Phase 1)Study completedNCT00479050
What this trial is testing

Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm

Who this might be right for
Hepatocellular Carcinoma
Shandong University 291
Post-approval studies (Phase 4)Study completedNCT00936689
What this trial is testing

Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE

Who this might be right for
Carcinoma, Hepatocellular
Rita Golfieri 178
Not applicableActive Not RecruitingNCT07065786
What this trial is testing

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

Who this might be right for
Transcatheter Arterial ChemoembolizationUnresectable Hepatocellular Carcinoma
Zhongda Hospital 550
Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Load More Results